Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| UCEC | Uterine Corpus Endometrial Carcinoma | G679G | Silent | 2 |
| BLCA | Bladder urothelial carcinoma | D43N | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E289K | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E289Q | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E562Q | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | G380A | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | K105K | Silent | 1 |
| BLCA | Bladder urothelial carcinoma | N9S | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | S264T | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | S516L | Missense | 1 |
| BRCA | Breast invasive carcinoma | N453K | Missense | 1 |
| BRCA | Breast invasive carcinoma | P577R | Missense | 1 |
| BRCA | Breast invasive carcinoma | V328V | Silent | 1 |
| CESC | Cervical and endocervical cancers | A610T | Missense | 1 |
| CESC | Cervical and endocervical cancers | E144Q | Missense | 1 |
| COAD | Colon adenocarcinoma | A82V | Missense | 1 |
| COAD | Colon adenocarcinoma | E169D | Missense | 1 |
| COAD | Colon adenocarcinoma | G221G | Silent | 1 |
| COAD | Colon adenocarcinoma | R458W | Missense | 1 |
| COAD | Colon adenocarcinoma | V416M | Missense | 1 |
| COAD | Colon adenocarcinoma | Y617C | Missense | 1 |
| ESCA | Esophageal carcinoma | R137L | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | A173V | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | F443L | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | G638D | Missense | 1 |
| KIRP | Kidney renal papillary cell carcinoma | I228M | Missense | 1 |
| LGG | Brain Lower Grade Glioma | Y342C | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | K65R | Missense | 1 |
| LUAD | Lung adenocarcinoma | C595Y | Missense | 1 |
| LUAD | Lung adenocarcinoma | G13R | Missense | 1 |
| LUAD | Lung adenocarcinoma | G330A | Missense | 1 |
| LUAD | Lung adenocarcinoma | V185L | Missense | 1 |
| LUSC | Lung squamous cell carcinoma | A8T | Missense | 1 |
| LUSC | Lung squamous cell carcinoma | G206R | Missense | 1 |
| LUSC | Lung squamous cell carcinoma | G606R | Missense | 1 |
| LUSC | Lung squamous cell carcinoma | R265M | Missense | 1 |
| LUSC | Lung squamous cell carcinoma | R266W | Missense | 1 |
| LUSC | Lung squamous cell carcinoma | Y650N | Missense | 1 |
| PAAD | Pancreatic adenocarcinoma | A173V | Missense | 1 |
| PAAD | Pancreatic adenocarcinoma | R531Q | Missense | 1 |
| PRAD | Prostate adenocarcinoma | R53Q | Missense | 1 |
| READ | Rectum adenocarcinoma | V214I | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | F555F | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | H23H | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | K457Q | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | M247I | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | S259L | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | S484S | Silent | 1 |
| STAD | Stomach adenocarcinoma | A155V | Missense | 1 |
| STAD | Stomach adenocarcinoma | F267F | Silent | 1 |
| STAD | Stomach adenocarcinoma | I199T | Missense | 1 |
| STAD | Stomach adenocarcinoma | N170K | Missense | 1 |
| STAD | Stomach adenocarcinoma | R529W | Missense | 1 |
| STAD | Stomach adenocarcinoma | S187S | Silent | 1 |
| STAD | Stomach adenocarcinoma | T388A | Missense | 1 |
| STAD | Stomach adenocarcinoma | V429V | Silent | 1 |
| TGCT | Testicular Germ Cell Tumors | A82V | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | A515A | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | E108D | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | G51C | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R137C | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R390* | Nonsense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | T179T | Silent | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 7.7 | 16 | 0 |
| BRCA | Breast invasive carcinoma | 976 | 7.7 | 4 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 0 | 4 | 0 |
| COAD | Colon adenocarcinoma | 367 | 7.7 | 10 | 0 |
| ESCA | Esophageal carcinoma | 185 | 0 | 2 | 0 |
| GBM | Glioblastoma multiforme | 283 | 0 | 0 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 0 | 6 | 0 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 0 | 0 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 0 | 2 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | 2 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 0 | 2 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 0 | 8 | 0 |
| LUSC | Lung squamous cell carcinoma | 177 | 0 | 12 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 0 | 0 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 0 | 4 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 0 | 2 | 0 |
| READ | Rectum adenocarcinoma | 122 | 0 | 2 | 0 |
| SARC | Sarcoma | 247 | 0 | 0 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 23.1 | 6 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 23.1 | 10 | 0 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 2 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 30.8 | 6 | 100 |